Phytonadione Injection, Emulsion
NDC Package 70095-154-02
Package Information
Phytonadione injection is vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. This formulation utilizes a injection, emulsion delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 70095-154 and is authorized under FDA application ANDA216298.
Identification & Billing
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Regulatory & Marketing
Hierarchy Structure
- 70095 - Sun Pharmaceutical Industries, Inc.
- 70095-154 - Phytonadione
- 70095-154-02 - 10 CARTON in 1 CARTON / 1 BLISTER PACK in 1 CARTON (70095-154-01) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE
- 70095-154 - Phytonadione
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70095-154-02 identifies a specific commercial package of 10 carton in 1 carton / 1 blister pack in 1 carton (70095-154-01) / 1 syringe in 1 blister pack / .5 ml in 1 syringe of Phytonadione, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This injection, emulsion is formulated for intramuscular; intravenous; subcutaneous use and contains phytonadione as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on June 10, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. These substances help your blood to thicken and stop bleeding normally (such as after an accidental cut or injury). Low levels of blood clotting factors increase the risk for unusual bleeding. Low levels may be caused by certain medications (such as warfarin) or medical conditions (such as obstructive jaundice). Vitamin K helps to treat and prevent unusual bleeding by increasing the body's production of blood clotting factors.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70095015402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.